Log In
Print this Print this

eptinezumab (IV ALD403)

Also known as: ALD403

  Manage Alerts
Collapse Summary General Information
Company Alder BioPharmaceuticals Inc.
DescriptionmAb targeting calcitonin gene-related peptide (CGRP)
Molecular Target Calcitonin gene-related peptide (CGRP)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase III
Standard IndicationMigraine
Indication DetailsPrevent chronic migraines; Prevent frequent episodic migraine
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today